ENOBIA PHARMA INC has a total of 17 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are PROTEON THERAPEUTICS INC, MATSUO HISAYUKI and MODERNA THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Canada | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Brazil | 1 | |
#6 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Organic fine chemistry | |
#5 | Measurement | |
#6 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Analysing materials | |
#7 | Acyclic or carbocyclic compounds | |
#8 | Animal care | |
#9 | Heterocyclic compounds | |
#10 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Boileau Guy | 12 |
#2 | Crine Philippe | 10 |
#3 | Lemire Isabelle | 10 |
#4 | Loisel Thomas P | 9 |
#5 | Landy Hal | 4 |
#6 | Heft Robert | 4 |
#7 | Leonard Pierre | 4 |
#8 | Moffatt Pierre | 3 |
#9 | Lanctot Christian | 3 |
#10 | Salois Patrick | 2 |
Publication | Filing date | Title |
---|---|---|
WO2008138131A1 | Bone targeted alkaline phosphatase, kits and methods of use thereof | |
US2007049521A1 | Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof | |
EP1572645A2 | Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex | |
EP1458749A2 | Bone polypeptide-1 | |
EP1311691A2 | Method and compositions for promoting osteogenesis |